PMID- 31600210 OWN - NLM STAT- MEDLINE DCOM- 20200312 LR - 20200426 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 14 IP - 10 DP - 2019 TI - Plasma mitochondrial DNA is elevated in obese type 2 diabetes mellitus patients and correlates positively with insulin resistance. PG - e0222278 LID - 10.1371/journal.pone.0222278 [doi] LID - e0222278 AB - Cells damaged by mechanical or infectious injury release proinflammatory mitochondrial DNA (mtDNA) fragments into the circulation. We evaluated the relation between plasma levels of mtDNA fragments in obese type 2 diabetes mellitus (T2DM) patients and measures of chronic inflammation and insulin resistance. In 10 obese T2DM patients and 12 healthy control (HC) subjects, we measured levels of plasma cell-free mtDNA with quantitative real-time polymerase chain reaction, and mtDNA damage in skeletal muscle with quantitative alkaline Southern blot. Also, markers of systemic inflammation and oxidative stress in skeletal muscle were measured. Plasma levels of mtDNA fragments, mtDNA damage in skeletal muscle and plasma tumor necrosis factor alpha levels were greater in obese T2DM patients than HC subjects. Also, the abundance of plasma mtDNA fragments in obese T2DM patients levels positively correlated with insulin resistance. To the best of our knowledge, this is the first published evidence that elevated level of plasma mtDNA fragments is associated with mtDNA damage and oxidative stress in skeletal muscle and correlates with insulin resistance in obese T2DM patients. Plasma mtDNA may be a useful biomarker for predicting and monitoring insulin resistance in obese patients. FAU - Yuzefovych, Larysa V AU - Yuzefovych LV AD - Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. FAU - Pastukh, Viktor M AU - Pastukh VM AD - Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. FAU - Ruchko, Mykhaylo V AU - Ruchko MV AD - Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. FAU - Simmons, Jon D AU - Simmons JD AD - Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. AD - Department of Surgery, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. FAU - Richards, William O AU - Richards WO AD - Department of Surgery, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. FAU - Rachek, Lyudmila I AU - Rachek LI AD - Department of Pharmacology, College of Medicine, University of South Alabama, Mobile, Alabama, United States of America. LA - eng GR - K08 GM109113/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20191010 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Biomarkers) RN - 0 (Blood Glucose) RN - 0 (DNA, Mitochondrial) SB - IM MH - Biomarkers/blood MH - Biopsy MH - Blood Glucose/genetics MH - DNA, Mitochondrial/*blood MH - Diabetes Mellitus, Type 2/*blood/complications/pathology MH - Female MH - Humans MH - Insulin Resistance/*genetics MH - Male MH - Muscle, Skeletal/metabolism MH - Obesity/*blood/complications/pathology MH - Oxidative Stress/genetics PMC - PMC6786592 COIS- The authors have declared that no competing interests exist. EDAT- 2019/10/11 06:00 MHDA- 2020/03/13 06:00 PMCR- 2019/10/10 CRDT- 2019/10/11 06:00 PHST- 2019/02/19 00:00 [received] PHST- 2019/08/26 00:00 [accepted] PHST- 2019/10/11 06:00 [entrez] PHST- 2019/10/11 06:00 [pubmed] PHST- 2020/03/13 06:00 [medline] PHST- 2019/10/10 00:00 [pmc-release] AID - PONE-D-19-04960 [pii] AID - 10.1371/journal.pone.0222278 [doi] PST - epublish SO - PLoS One. 2019 Oct 10;14(10):e0222278. doi: 10.1371/journal.pone.0222278. eCollection 2019.